Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Verici Dx Plc | LSE:VRCI | London | Ordinary Share | GB00BM8HZD43 | ORD GBP0.001 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.625 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 2.50 | 2.75 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Business Services, Nec | USD 1.01M | USD -8.73M | USD -0.0360 | -0.83 | 6.37M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 2.625 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 14/1/2025 | 11:01 | UK RNS | Verici Dx PLC Holding(s) in Company |
| 11/10/2024 | 11:22 | ALNC |  Verici Dx delayed coverage determination pushes back Tutivia revenue |
| 11/10/2024 | 06:00 | UK RNS | Verici Dx PLC Update on Local Coverage Determination and Trading |
| 31/7/2024 | 06:00 | UK RNS | Verici Dx PLC Launch of PTRA Assay using Verici Dx's technology |
| 15/7/2024 | 18:36 | ALNC | EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises |
| 15/7/2024 | 06:00 | UK RNS | Verici Dx PLC Half-year Report |
| 11/7/2024 | 13:00 | UK RNS | Verici Dx PLC Notice of Results and Business Update |
| 01/7/2024 | 13:27 | ALNC | IN BRIEF: Verici Dx hails milestone payment in deal with Thermo Fisher |
| 01/7/2024 | 06:00 | UK RNS | Verici Dx PLC Significant milestone re Thermo Fisher agreement |
| 25/6/2024 | 12:27 | UK RNS | Verici Dx PLC Result of AGM |
Verici Dx (VRCI) Share Charts1 Year Verici Dx Chart |
|
1 Month Verici Dx Chart |
Intraday Verici Dx Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 15/3/2025 | 12:11 | Verici DX- Break through immuno-diagnostic test | 1,062 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 16/3/2025 08:20 by Verici Dx Daily Update Verici Dx Plc is listed in the Business Services, Nec sector of the London Stock Exchange with ticker VRCI. The last closing price for Verici Dx was 2.63p.Verici Dx currently has 242,541,467 shares in issue. The market capitalisation of Verici Dx is £7,276,244. Verici Dx has a price to earnings ratio (PE ratio) of -0.83. This morning VRCI shares opened at - |
Posted at 14/3/2025 19:18 by earwacks Certainly my feeling. Did you try putting in a big buy order? There is always something to compound the issue. So we have Amati allegedly clearing out their holdings in AIM stocks (which I’m not 100 per cent sure about) they and Octopus seem to run two each holding Vrci shares . A delay in the news about completion of approval and a bunch of market makers that know full well this is potentially the hottest stock on AIM. I’m a buyer as and when funds allow. Full year results due in a couple of months. |
Posted at 14/3/2025 16:49 by cyberbub The late trade of 408k at 2.60p, marked as a sell, looks like a possible buy to me, as I could get a quote to sell 500k at around the same time, at 2.53p. Either that, or there's a larger delayed buy of 1M or so in the system at a price above 2.60p....? I can't believe that the MMs would bid for shares in an illiquid smallcap like this, if they didn't have someone who had already bought them? ie a tree shake.NAI |
Posted at 07/3/2025 09:22 by ach1lles7 200,000 sold well below the bidNot looking good :( bri15 You best start buying , otherwise the price will fall even further |
Posted at 07/3/2025 08:26 by earwacks It is true that the £30,000 trade was a buy as reported at the time on london stock exchange but you can buy at 3.4p currently. Lets not get over excited gentlemen. I believe in RNA diagnostics. This looks very promising. Whats not so clear is the Amati fund position. It looks like they have sold down to just over 1%. They maybe nearly cleared out by now. We will get news when it is ready. Director are not in the habit of commentating on the vagaries of stock price movements otherwise they would never get any work done, especially in this market! Gl |
Posted at 06/3/2025 11:51 by z1co This has fallen from over 10p on worries regarding Tutivia , once we get official confirmation from the company the share price will multibag.From their last update: We remain pleased with the initial TutiviaTM test ordering, the levels of repeat ordering, and expect volumes to accelerate as insurance coverage is established in 2025. |
Posted at 11/2/2025 09:31 by earwacks Amati have been offloading from their 6 percent holding . We dont what they have left because its not notifiable anymore. The excuse given is their Aim holdings have performed badly. A fair amount of restructure is going on within their funds so unfortunately or fortunately depending on your view of opportunity the market is very weak currently. Even small sales are hammering share prices. If someone is offloading, somebody else is buying. They said they had enough cash not to need to raise anymore. Their should be an announcement made on the delay flagged up in october and hopefully the proceeds from that delay, due by March. The market does its thing and the business does something else. The two are often at a complete disconnect as is evident in many stocks at the moment. Just look at fund redemptions. |
Posted at 30/1/2025 22:54 by simonrowan52 I was being cynical about fund managers. They probably are selling at a massive loss and going to see if they can halve it again. Redemptions are playing havoc with share prices. Just have to grit your teeth and plough on through. I will certainly be keen to add to my position here. Have to guess when the seller is done. Must be nearly there. |
Posted at 03/12/2024 14:31 by sirshagalot Rewards come to those who wait.The share price was expected to drop but i didnt think it would drop as much, however the potential stays the same its all about news. I hold these and will buy some more if the price lowers much more, i love to nibble at stocks and i also get free trades per month. Still a bit of time for news , i expect some around feb its a waiting game at this juncture. Please dyor and merry xmas to all |
Posted at 02/12/2024 21:24 by collywobbler Very interesting and positive bit of news . Can they not afford to put it into a RNS? Cards on the table I’ve sold my Verici shares and I’ve also closed my trading account seeing as it’s so rubbish for n AIM. If this does anything to the share price I will be slightly envious but then again it will have to do over 100 percent from here and I still sold at the right time. Sorry to be a downer on everything but there is no immediate revenue in this so it goes on the positive future pile. And that don’t do. Nothing to an aim share . All the best and you’ll be glad to hear I won’t post again! |
Posted at 18/11/2024 09:32 by m_night10 #POLX stronger cash position and higher revenues and growth.POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval. Massive takeover target and will be sold for 20p+ share price. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
